Aspira Women’s Health Inc.: proceeds from issuing common stock
Proceeds from issuing common stock for Aspira Women’s Health Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All Aspira Women’s Health Inc. financial histories
What this measure means
Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.
Exact concept: us-gaap:ProceedsFromIssuanceOfCommonStock. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2010-01-01 to 2023-12-31. The SEC response was captured on 2026-09-20.
This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2023-01-01 | 2023-12-31 | 202,000 | USD | 2024-04-01 | 10-K · 0000926617-24-000015 |
| 2022-01-01 | 2022-12-31 | 9,000,000 | USD | 2023-10-26 | 10-K/A · 0000926617-23-000089 |
| 2021-01-01 | 2021-12-31 | 48,235,000 | USD | 2023-10-26 | 10-K/A · 0000926617-23-000089 |
| 2019-01-01 | 2019-12-31 | 13,521,000 | USD | 2021-03-31 | 10-K · 0000926617-21-000033 |
| 2018-01-01 | 2018-12-31 | 8,990,000 | USD | 2020-04-07 | 10-K · 0000926617-20-000015 |
| 2011-01-01 | 2011-12-31 | 20,206,000 | USD | 2013-03-01 | 10-K · 0001193125-13-087647 |
| 2010-01-01 | 2010-12-31 | 42,782,000 | USD | 2012-03-27 | 10-K · 0001193125-12-132712 |
Related financial histories
- Aspira Women’s Health Inc.: total assets
- Aspira Women’s Health Inc.: total liabilities
- Aspira Women’s Health Inc.: stockholders equity
- Aspira Women’s Health Inc.: cash and cash equivalents
- Aspira Women’s Health Inc.: net income or loss
- Aspira Women’s Health Inc.: operating cash flow
- Aspira Women’s Health Inc.: capital expenditure payments
- Aspira Women’s Health Inc.: revenue
- Aspira Women’s Health Inc.: contract revenue excluding tax
- Aspira Women’s Health Inc.: financing cash flow
- Aspira Women’s Health Inc.: investing cash flow
- Aspira Women’s Health Inc.: retained earnings or deficit
- Aspira Women’s Health Inc.: basic weighted-average shares
- Aspira Women’s Health Inc.: diluted weighted-average shares
- Aspira Women’s Health Inc.: basic earnings per share
- Aspira Women’s Health Inc.: diluted earnings per share
- Aspira Women’s Health Inc.: net property, plant and equipment
- Aspira Women’s Health Inc.: share-based compensation expense
- Aspira Women’s Health Inc.: operating income or loss
- Aspira Women’s Health Inc.: current assets
- Aspira Women’s Health Inc.: interest expense
- Aspira Women’s Health Inc.: current liabilities
- Aspira Women’s Health Inc.: current accounts payable
- Aspira Women’s Health Inc.: net current accounts receivable
- Aspira Women’s Health Inc.: operating expenses
- Aspira Women’s Health Inc.: net inventory
- Aspira Women’s Health Inc.: gross profit
- Aspira Women’s Health Inc.: research and development expense
- Aspira Women’s Health Inc.: common shares outstanding
- Aspira Women’s Health Inc.: cash including restricted cash
- Aspira Women’s Health Inc.: additional paid-in capital
- Aspira Women’s Health Inc.: accumulated other comprehensive income or loss
- Aspira Women’s Health Inc.: total equity including noncontrolling interests
- Aspira Women’s Health Inc.: operating lease right-of-use asset
- Aspira Women’s Health Inc.: operating lease liability
- Aspira Women’s Health Inc.: long-term debt
- Aspira Women’s Health Inc.: gross property, plant and equipment
- Aspira Women’s Health Inc.: accumulated depreciation on property, plant and equipment
- Aspira Women’s Health Inc.: other noncurrent assets
- Aspira Women’s Health Inc.: other noncurrent liabilities
- Aspira Women’s Health Inc.: accrued current liabilities
- Aspira Women’s Health Inc.: prepaid expenses and other current assets
- Aspira Women’s Health Inc.: net deferred tax assets
- Aspira Women’s Health Inc.: pre-tax income or loss from continuing operations
- Aspira Women’s Health Inc.: comprehensive income or loss
- Aspira Women’s Health Inc.: net income available to common stockholders
- Aspira Women’s Health Inc.: general and administrative expense
- Aspira Women’s Health Inc.: depreciation expense
- Aspira Women’s Health Inc.: depreciation, depletion and amortization
- Aspira Women’s Health Inc.: other nonoperating income or expense
- Aspira Women’s Health Inc.: nonoperating income or expense
- Aspira Women’s Health Inc.: interest paid, net
- Aspira Women’s Health Inc.: operating lease payments
- Aspira Women’s Health Inc.: change in accounts receivable
- Aspira Women’s Health Inc.: change in inventories
- Aspira Women’s Health Inc.: change in accounts payable
Inspect the source
- Entity
- Aspira Women’s Health Inc. / CIK 0000926617
- Captured
- 2026-09-20T05:08:46.532Z
- SEC response SHA-256
4aa7c80ecb27ea79b0d5b639913356a502fdcf1c28d7b8cfb49990c080ce3770
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000926617.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))